Undervalued Stocks in the Nasdaq Composite Index April 2025

April 07, 2025

Nasdaq Composite Index

The Nasdaq 100 is a stock market index made up of 101 equity securities issued by 100 of the largest non-financial companies listed on the Nasdaq stock exchange.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued stocks in the Nasdaq Composite Index

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
BIIB Biogen 122.98 212.23 72.57 1804439 17943 0.00 11.0
REGN Regeneron Pharmaceuticals 573.45 913.44 59.29 1033424 66004 0.15 15.0
AMZN Amazon.com 171.00 265.14 55.05 51618964 1833291 0.00 30.9
WDAY Workday 217.14 324.60 49.49 2290324 58455 0.00 111.4
GFS GLOBALFOUNDRIES 31.54 46.60 47.76 2576897 17442 0.00 0.0
CMCSA Comcast 33.38 43.20 29.42 28371315 130449 3.77 8.1
GEHC GE HealthCare Techs 60.50 74.64 23.38 4388091 27770 0.21 13.9
SBUX Starbucks 82.10 100.30 22.16 10302086 93463 2.87 26.5
FTNT Fortinet 84.71 103.41 22.07 4928617 65388 0.00 37.5
MU Micron Technology 64.72 77.90 20.37 25324755 72681 0.71 15.5
All data provided as at market close April 03, 2025.

Company Details

Biogen

BIIB:NAS

Close Price

122.98

Our Valuation

212.23

% Difference

72.57

Market Cap ($M)

17943

P/E Ratio

11.0

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity.

Access the stockcalc valuation


Regeneron Pharmaceuticals

REGN:NAS

Close Price

573.45

Our Valuation

913.44

% Difference

59.29

Market Cap ($M)

66004

P/E Ratio

15.0

Regeneron Pharmaceuticals Inc discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis.

Access the stockcalc valuation


Amazon.com

AMZN:NAS

Close Price

171.00

Our Valuation

265.14

% Difference

55.05

Market Cap ($M)

1833291

P/E Ratio

30.9

Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 75% of total, followed by Amazon Web Services' cloud computing, storage, database, and other offerings (15%), advertising services (5% to 10%), and other the remainder. International segments constitute 25% to 30% of Amazon's non-AWS sales, led by Germany, the United Kingdom, and Japan.

Access the stockcalc valuation


Workday

WDAY:NAS

Close Price

217.14

Our Valuation

324.60

% Difference

49.49

Market Cap ($M)

58455

P/E Ratio

111.4

Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions for enterprises. Known for being a cloud-only software provider, Workday was founded in 2005 and is headquartered in Pleasanton, California.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

GLOBALFOUNDRIES

GFS:NAS

Close Price

31.54

Our Valuation

46.60

% Difference

47.76

Market Cap ($M)

17442

P/E Ratio

0.0

GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates.

Access the stockcalc valuation


Comcast

CMCSA:NAS

Close Price

33.38

Our Valuation

43.20

% Difference

29.42

Market Cap ($M)

130449

P/E Ratio

8.1

Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to 63 million US homes and businesses, or nearly half of the country. About 50% of the locations in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011.

Access the stockcalc valuation


GE HealthCare Techs

GEHC:NAS

Close Price

60.50

Our Valuation

74.64

% Difference

23.38

Market Cap ($M)

27770

P/E Ratio

13.9

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively.

Access the stockcalc valuation


Starbucks

SBUX:NAS

Close Price

82.10

Our Valuation

100.30

% Difference

22.16

Market Cap ($M)

93463

P/E Ratio

26.5

Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 40,000 stores across more than 80 countries as of the end of fiscal 2024. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage).

Access the stockcalc valuation


Fortinet

FTNT:NAS

Close Price

84.71

Our Valuation

103.41

% Difference

22.07

Market Cap ($M)

65388

P/E Ratio

37.5

Fortinet is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, zero-trust access, and security operations. The firm derives a majority of its revenue through sales of its subscriptions and support-based business. The California-based firm has more than 800,000 customers across the world.

Access the stockcalc valuation


Micron Technology

MU:NAS

Close Price

64.72

Our Valuation

77.90

% Difference

20.37

Market Cap ($M)

72681

P/E Ratio

15.5

Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Biogen and Regeneron Pharmaceuticals are the most undervalued stocks on the Nasdaq Composite Index. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-stocks-in-nasdaq-composite-index-april-2025
Biogen $BIIB and Regeneron Pharmaceuticals $REGN are the most undervalued stocks on the Nasdaq Composite Index. See which other companies made the list: https://www.stockcalc.com/Blog/undervalued-stocks-in-nasdaq-composite-index-april-2025
Biogen and Regeneron Pharmaceuticals are the most undervalued stocks on the Nasdaq Composite Index. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-stocks-in-nasdaq-composite-index-april-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.